Release Date: 08/12/15 09:14 Summary: Satisfaction & Waiver of All Bid Conditions to Acquire 4D-S Price Sensitive: No Download Document 109.31KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status